Cipher Pharmaceuticals Schedules Q4 & Fiscal 2025 Earnings Release and Conference Call

Cipher Pharmaceuticals Schedules Q4 & Fiscal 2025 Earnings Release and Conference Call Canada NewsWire MISSISSAUGA, ON, March 4, 2026 MISSISSAUGA, ON, March 4, 2026 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) ("Cipher" or the "Company") today announced that it will release its financial results for the fourth quarter and fiscal 2025 after the market close on Thursday, March 12, 2026. The Company will also hold a conference call on Friday, March 13, 2026 at 8:30am ET to discuss the results and corporate developments. CONFERENCE CALL DETAILS DATE:                                                                    Friday, March 13, 2026 TIME:                                                                     8:30 a.m. ET DIAL-IN NUMBER:                                                416-945-7677 or 888-699-1199 REPLAY:                                                               289-819-1450 or 888-660-6345 Code: 29916#                                                                               Expires: March 20, 2026 WEBCAST:                                                           https://app.webinar.net/G7lE687Woew About Cipher Pharmaceuticals Inc. Cipher Pharmaceuticals (TSX: CPH) (OTCQX: CPHRF) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products in Canada, the U.S., and South America. For more information, visit www.cipherpharma.com. SOURCE Cipher Pharmaceuticals Inc. View original content: http://www.newswire.ca/en/releases/archive/March2026/04/c0312.html Contact: For further information: Graham Farrell, Investor Relations - Cipher Pharmaceuticals, [email protected], 416-842-9003